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Abstract
Secondary cryoglobulinemia is the most common extrahepatic manifestation of hepatitis C. There are different geno-
types of hepatitis C, and the ones that are most frequently associated with cryoglobulinemia are genotypes 1b and 
2a. Cryoglobulinemia affects various organs and can cause vasculitis, arthralgia, skin changes, glomerulonephritis 
and neurological manifestations, including peripheral neuropathy. The aim of this report was to emphasize the im-
portance of early diagnosis of hepatitis C infection in patients who are presenting with sensomotor polyneuropathy.
Sažetak
Sekundarna krioglobulinemija najčešća je ekstrahepatalna manifestacija hepatitisa C. Postoje različiti genotipovi 
hepatitisa C, a najčešće povezani s krioglobulinemijom su genotipovi 1b i 2a. Krioglobulinemija može dovesti do 
različitih organskih oštećenja te rezultirati brojnim komplikacijama poput vaskulitisa, artralgija, promjena na koži, 
glomerulonefritisa i neuroloških manifestacija, uključujući perifernu neuropatiju. Cilj ovog prikaza bolesnika je 
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Introduction
 Secondary cryoglobulinemia is the most common 
extrahepatic manifestation of hepatitis C[1]. There are 
different genotypes of hepatitis C, and the ones that 
are most frequently associated with cryoglobulinemia 
are genotypes 1b and 2a[2]. Cryoglobulinemia affects 
various organs and can cause vasculitis, arthralgia, 
skin changes, glomerulonephritis and neurological 
manifestations, including peripheral neuropathy. Cry-
oglobulins are immunoglobulins that produce precip-
itate or gel in reduced temperatures. These precipitate 
dissolve when the temperature returns to normal val-
ues[3,4]. Cryoglobulinemia can be essential - without a 
detectable underlying disease, or it can be secondary 
to other conditions, such as an infection (most com-
monly hepatitis C)[5], lymphoproliferative or an auto-
immune disease. It can lead to a variety of systemic 
complications, including peripheral neuropathy[3].
 The aim of this report was to emphasize the impor-
tance of early diagnosis of hepatitis C infection in patients 
who are presenting with sensorimotor polyneuropathy.
Case report
Patient information and clinical findings
 A 69-year-old woman was admitted to the Depart-
ment of Neurology in August 2016 due to progressive 
gait difficulties with distal motor weakness of extrem-
ities, tingling sensation in the hands and feet, and skin 
changes.
 The symptoms began in December 2015 after over-
coming the flu when the patient developed gradual 
numbness and weakness of both hands and feet. In 
February 2016, tests for paraneoplastic syndrome were 
performed, which came back negative and the patient 
was diagnosed with polyneuropathy of unknown 
cause. She was prescribed methylprednisolone in dos-
age of 4 mg per day that she stopped using of her on 
own initiative after two months. Several months later, 
the patient developed new symptoms, now including 
polyarthritis affecting small joints and both ankles. 
One month later, due to spinal stenosis that was de-
scribed on MR imaging, she was referred to spine sur-
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 Serologic studies for viral hepatitis were performed 
and came positive for HCV virus (genotype 1b, 240745 IU 
RNA/ml). The tests for hepatitis B and HIV were negative.
 In further investigation, skin biopsy was performed 
and revealed leukocytoclastic vasculitis with necrosis 
(Figure 1b).
Figure 1b. Leukocytoclastic vasculitis with necrosis
Slika 1b. Leukocitoklastični vaskulitis s nekrozom
Therapeutic interventions
 The patient was diagnosed with cryoglobulinemia 
and treated with high doses of glucocorticosteroids 
during initial hospitalisation (1000 mg for three days 
following with 500 mg for two days). She was dis-
charged home with prescribed immunosuppressive 
therapy (prednisone) and antiviral therapy (ombitas-
vir, paritaprevir and ritonavir + dasubavir) for hepa-
titis C. On follow-up exams there was a gradual and 
substantial recovery of skin lesions (Figure 1c), erad-
ication of chronic HCV infection with significant im-
provement in motor strength (4/5) of the legs.
Figure 1c. Reduction of skin lesions on follow-up
Slika 1c. Smanjenje kožnih lezija na kontrolnom pregledu
Discussion
 Hepatitis C infection is related to various intrahe-
patic and extrahepatic manifestations, and cryoglob-
ulinemia is believed to be one of the most common 
extrahepatic expressions[1,5].
gery which resulted in short-term subjective improve-
ment. However, the tingling sensations in both hands 
and feet persisted, and one month later she developed 
gait difficulties and now required crutches for walking. 
Later, in June 2016, the patient developed severe neu-
ropathic pain in distal extremities with skin changes 
on her ankles. She was then prescribed amitriptyline 
and pregabalin. In August 2016, the gait got progres-
sively worse with swelling of the joints and prominent 
skin changes (Figure 1a) due to which the patient was 
admitted to our Department.
Figure 1a. Skin changes before treatment
Slika 1a. Kožne promjene prije liječenja
 Past medical history revealed arterial hypertension 
and surgery of the kidney in the childhood that re-
quired blood transfusion.
 Neurological examination at admission revealed 
distal motor weakness with hypotrophy, paraesthesia 
in „stocking – glove” distribution, absent pain and 
vibration sensation of the feet, and absent Achilles 
reflexes, while the physical examination revealed skin 
ulcerations of the lower extremities.
Diagnostic assessment
 Laboratory testing showed elevated sedimentation 
rate (ESR) and C-reactive protein (CRP) levels, while 
immunological testing revealed normal ANA; p-AN-
CA, c-ANCA, anti-CCP anti dsDNA levels, increased 
RF and CIC, C4 hypocomplementemia and positive 
cryoglobulin type III. Tumour markers were retested 
and came back negative, vitamin B12 and folate levels 
came back within the range.
 Electromyoneurography revealed severe, predomi-
nantly axonal sensorimotor polyneuropathy.
 Neuroradiological imaging (MR of the cervical and 
lumbar spine), did not reveal any significant findings, 
and lumbar puncture revealed a slightly increased pro-
tein level (0,51 g/L) with normal cell counts (5 cells) 
and normal CSF glucose levels.
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initiated and on the presenting symptoms[2,7,9]. Our 
patient was treated with corticosteroids and antiviral 
therapy which resulted in recovery of skin lesions, 
eradication of HCV infection and significant improve-
ment in motor strength, with residual very mild distal 
motor leg weakness. Despite the long period between 
the symptoms onset, diagnosis and the treatment, our 
patient had very good clinical improvement.
 In everyday clinical practice, early recognition of 
cryoglobulinemia and confirmation of hepatitis C in-
fection in patients with sensomotor polyneuropathy 
may enable early treatment and better functional out-
come with reduced possibility of permanent neurolog-
ical damage.
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 In most cases, cryoglobulinemia is asymptomatic. 
However, patients who develop symptoms can present 
with arthralgia, cutaneous changes, vasculitis of vari-
ous severity, renal and neurological complications[1,2].
Not every HCV infection will be accompanied by 
cryoglobulinemia and not every genotype of HCV is 
equally represented. Our patient was diagnosed with 
type 1b, a genotype that was previously described in 
studies as one that is most commonly associated with 
cryoglobulinemia[2].
 Furthermore, organ involvement and patient symp-
toms vary greatly, and not all symptoms are represent-
ed equally in every patient. It has been reported that 
neurological symptoms are more present in patients 
with type 1b and 3 than in other types[2]. However, the 
reason for this is not yet completely understood[6].
 Regarding the neurological manifestations, var-
ious authors have reported both central and periph-
eral neurological complications. Central neurological 
manifestations were sporadic and included individual 
cases of seizures, intracerebral haemorrhage, cerebral 
vasculitis and meningitis[7]. More common neurolog-
ical complications were those of peripheral nerves. 
These were polyneuropathy, small fibre neuropathy 
and mononeuritis multiplex[7].
 Our patient was asymptomatic for many years. The 
first manifestation included sensory nerve involve-
ment, followed by polyarthralgia and skin changes. 
She was later on diagnosed with sensorimotor pol-
yneuropathy, which has been reported as one of the 
most common neurological complications[6,7].
 Available treatment is focused on the underlying 
disease and includes specific and symptomatic therapy 
– most commonly corticosteroids, cytostatics, antivi-
ral therapy, plasmapheresis and intravenous immuno-
globulin[7]. Immunosuppressive or immunomodulatory 
therapy, including steroids, plasmapheresis and cyto-
toxic agents, is reserved for organ-threatening manifes-
tations[8]. Symptomatic treatment includes treatment of 
neuropathic pain with pain-modifying agents, includ-
ing amitriptyline/nortriptyline, duloxetine, gabapentin, 
or pregabalin and NSAIDs that are used for the treat-
ment of arthritis or arthralgia symptoms[9].
 The reported success of the treatment is variable 
and greatly depends on the time when the therapy was 
